Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001370348-26-000002

Options or other derivatives

  • Director acquired 23,931 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Johnson Craig A Director 2026-06-04 Grant or award · Director Stock Option (right to buy) +23,931 23,931 D: show line 1 in the form
Loading xslF345X06/wk-form4_1780949641.xml…